C91.10
Chronic lymphocytic leukemia of B-cell type not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Chronic lymphocytic leukemia of B-cell type with failed remission
- Chronic lymphocytic leukemia of B-cell type NOS
Medical Intelligence & Overview
Chronic lymphocytic leukemia (CLL) is a type of cancer that originates in the blood and bone marrow. It primarily affects a specific kind of white blood cell known as B lymphocytes, which are vital for the immune system. When CLL does not respond to treatment and fails to go into remission, it is categorized under a more advanced stage, indicating ongoing disease activity. This condition is a slow-growing form of leukemia, often progressing gradually over time. Patients typically experience subtle symptoms initially, and diagnosis often occurs during routine blood tests. Understanding the nature of this disease can help patients and caregivers better grasp its implications and management options.
Causes & Symptoms
Clinical Causes: Genetic mutations or abnormalities in B lymphocytes Family history of leukemia or other blood cancers Age-related changes, as CLL is more common in older adults Environmental exposures, such as certain chemicals or radiation (though the link remains unclear)
Key Symptoms: Persistent fatigue and weakness Swollen lymph nodes, especially in the neck, armpits, or groin Unexplained weight loss Frequent infections or increased susceptibility to illnesses Fever or night sweats Easy bruising or bleeding Enlarged spleen or liver Shortness of breath in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing CLL involves a combination of blood tests, physical examinations, and sometimes bone marrow biopsy. Blood tests may reveal an increased number of mature-looking lymphocytes. Flow cytometry is used to identify the specific markers on the surface of these cells, confirming the B-cell origin. Additional tests like imaging studies may assess the extent of lymph node or organ involvement. Since CLL can be asymptomatic initially, routine blood work often leads to its detection during health check-ups.
Treatment Protocols: Treatment options for CLL aim to control symptoms, slow disease progression, and improve quality of life. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C91.10 a billable ICD-10 code?
Yes, C91.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.10?
Clinical documentation must specify the nature of Chronic lymphocytic leukemia of B-cell type not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference